NCT04688580View on ClinicalTrials.gov

Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 29, 2020

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
Healthy
Interventions
DRUG

XW10172

Various formulations

Trial Locations (1)

5000

CMAX, Adelaide

Sponsors

Lead Sponsor

XWPharma
All Listed Sponsors
lead

XWPharma

INDUSTRY

NCT04688580 - Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter